INVESTOR RELATIONS
OSA Market Opportunity
Diagnosed Sleep Apnea Patients
TAM
140 M
Global
Mild, mod OSA
SAM
51 M
USA
Total OSA
SOM
30 M
60% SAM
mild, moderate
$8.81B
New market
($288+ per pt in ARR)
STAKEHOLDER IMPACT
Sleep, Primary Care, Cardio
-
Revenue per patient ($120/month)
-
Value-based care, shared savings
-
Manage outcomes effectively
-
Reduce labor burden
Healthcare System
-
Reduce readmission rates
-
Lower healthcare utilization
-
Elevated standard of care
-
Sleep data interoperability
Dental Sleep Practice
-
Increase patient base
-
Less chair time to titrate
-
More new patient revenue
-
Elevated standard of care
Sleep Apnea Patients
-
Access to preferred therapy
-
Data-driven actionables
-
Better quality of life
-
Increased adherence
News and Published Papers
Rob Kibler, Asim Roy, Brandon Canfield and Duane Mancini discuss their work in the sleep monitoring space, how they chose their beachhead market in dental, what they have learned so far, and so much more.
Elio Harmon, from the 614Startups podcast, interviews Asim Roy and Rob Kibler from Dianyx Innovations. They discuss the challenges of sleep apnea, the limitations of current treatments like CPAP and surgery, and how Dianyx's technology aims to revolutionize the oral appliance therapy market.
